Medical News Today -
7 Mar 2014 18:00
There is evidence that the brain changes associated with Alzheimer's disease begin many years before clinical symptoms like memory loss and mental decline emerge. With this in mind, biomarkers of these changes could be valuable ways to identify individuals at the "preclinical" stage, which is early enough for brain-preserving treatment to be effective.
Share this Article